Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 7, 2017
Previous Article Next Article

Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights

Author affiliations

Abstract

Covering: up to 2017

The overwhelming majority of antibiotics in clinical use originate from Gram-positive Actinobacteria. In recent years, however, Gram-negative bacteria have become increasingly recognised as a rich yet underexplored source of novel antimicrobials, with the potential to combat the looming health threat posed by antibiotic resistance. In this article, we have compiled a comprehensive list of natural products with antimicrobial activity from Gram-negative bacteria, including information on their biosynthetic origin(s) and molecular target(s), where known. We also provide a detailed discussion of several unusual pathways for antibiotic biosynthesis in Gram-negative bacteria, serving to highlight the exceptional biocatalytic repertoire of this group of microorganisms.

Graphical abstract: Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights

Back to tab navigation

Publication details

The article was received on 31 Jan 2017 and first published on 26 Jun 2017


Article type: Review Article
DOI: 10.1039/C7NP00010C
Citation: Nat. Prod. Rep., 2017,34, 712-783

  •   Request permissions

    Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights

    J. Masschelein, M. Jenner and G. L. Challis, Nat. Prod. Rep., 2017, 34, 712
    DOI: 10.1039/C7NP00010C

Search articles by author

Spotlight

Advertisements